Results 141 to 150 of about 155,831 (331)

Enolase-1 is a therapeutic target in endometrial carcinoma [PDF]

, 2015
Mengyang Zhao, Weiyi Fang, Yan Wang, Suiqun Guo, Luyun Shu, Lijing Wang, Yiyu Chen, Qiaofen Fu, Yan Liu, Shengni Hua, Yue Fan, Yiyi Liu, Xiaojie Deng, Rongcheng Luo, Mei Zhong, Qinping Jiang, Zhen Liu   +16 more
openalex   +1 more source

Renal cell carcinoma with atypical omental metastasis: A case report and literature review

UroPrecision, EarlyView.
Abstract Background Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults, with common metastatic sites including the lungs, bones, liver, and brain. Omental metastasis is exceedingly rare and usually occurs postoperatively. Fumarate hydratase‐deficient (FH‐deficient) RCC, a recently classified and highly aggressive subtype of ...
Andrew Jing, Zachary Guo, Katherine Wu, Wei Wang, James Jing   +4 more
wiley   +1 more source

Endometrial Carcinoma Metastatic to the Clitoris: A Case Report and Review of the Literature

Acta Medica Iranica, 2013
Endometrial cancer generally carries a good prognosis. Endometrial carcinoma more frequently metastasizes to the pelvic and para-aortic nodes. Visceral metastases usually occur in the vagina and ovaries.
Fereshteh Fakor, Hadi Hajizadeh Falah, Sina Khajeh Jahromi   +2 more
doaj  

Clinico-Radiological and Histopathological Study of Endometrial Lesions in Patients Presenting with Abnormal Uterine Bleeding

Journal of Medical Sciences and Health
Background: Abnormal uterine bleeding [AUB] is one of the most common presentations among women of all age groups. It is ‘Bleeding from the uterine corpus that is abnormal in volume, regularity or timing for the majority of last 6 months. Common
Swati Pundir, Manish Kumar, Usha Joshi, Sheela Chaudhari   +3 more
doaj   +1 more source

54 A prospective randomised study of open versus robotic assisted para aortic lymph node dissection in high risk endometrial carcinoma – a novel technique [PDF]

, 2019
Vijay Ahuja, S. P. Somashekhar, K. R. Ashwin, Rohit Kumar, Ramya Yethadka   +4 more
openalex   +1 more source

Identification of genetically predicted protein biomarkers and drug targets for prostate cancer via Mendelian randomization

VIEW, EarlyView.
Prostate cancer, a leading cause of cancer in men globally, urgently requires improved diagnostic and treatment strategies. This study analyzed large genetic datasets and identified five key proteins (THBD, DST, IFI27L2, OSBPL10, PPP1R14A) that either increase or decrease cancer risk, while also exploring their roles in immune response and potential ...
Maoping Cai, Tianming Peng, Zhiyue Xie, Chuqian Zhen, Chen Yao, Nan Peng, Qianyi Li, Yuzhong Yu, Jiming Bao, Xian‐Lu Song, Mingkun Chen, Shan‐Chao Zhao   +11 more
wiley   +1 more source

Resecting Beyond the Central Pelvic Compartment in Pelvic Exenterations for Gynaecological Malignancies: Outcomes From a Tertiary Unit

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background Pelvic exenterations (PE) in solid organ gynaecological malignancies have historically been confined to the central pelvic compartment but an expansion of resection extent to include the lateral compartment is now technically feasible. There remains uncertainty about its influence on outcomes.
Chia Yew Kong, Norman J. Galbraith, Aiste McCormick, Amy Haddock, Michael Ratcliffe, John Telfer, Steven Lo, Neil Fairbairn, Michael Palmer, Seamus Teahan, Simon Morton, Rhona Lindsay, Kevin Burton, Nadeem Siddiqui, Campbell S. Roxburgh, Peter S. Chong, Colin W. Steele, Martha Quinn   +17 more
wiley   +1 more source

Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma [PDF]

, 2021
Xiaohong Ma, Tianyi Zhao, Hong Yan, Kui Guo, Zhiming Liu, Lina Wei, Wei Lü, Chunping Qiu, Jie Jiang   +8 more
openalex   +1 more source

The impact of Foxp3+ regulatory T‐cells on CD8+ T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley   +1 more source

Sexual Function After Intracavitary Vaginal Brachytherapy for Early-Stage Endometrial Carcinoma

, 2012
Allison Quick, Leigh G. Seamon, Mahmoud Abdel‐Rasoul, Ritu Salani, Douglas Martin   +4 more
openalex   +2 more sources